New therapy is tolerable in lung cancer

A promising new therapy for the most common form of lung cancer appears to produce largely manageable side effects, and an ongoing clinical trial is determining whether the compound treats tumors more effectively than what's ...

May 31, 2013
popularity 5 / 5 (1) | comments 0

TCE exposure linked to increased risk of some cancers

Trichloroethylene (TCE) exposure has possible links to increased liver cancer risk, and the relationship between TCE exposure and risks of cancers of low incidence and those with confounding by lifestyle and other factors ...

May 30, 2013
popularity not rated yet | comments 0

Immune system to fight brain tumors

Research at Lund University in Sweden gives hope that one of the most serious types of brain tumour, glioblastoma multiforme, could be fought by the patients' own immune system. The tumours are difficult to remove with surgery ...

May 30, 2013
popularity 5 / 5 (2) | comments 1

New drugs, diagnostic approved for advanced melanoma

(HealthDay)—Two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), have been approved by the U.S. Food and Drug Administration to treat advanced melanoma, the most dangerous form of skin cancer.

May 29, 2013
popularity 5 / 5 (2) | comments 0

Colon cancer screening: Immunological tests are superior

Tests for hidden traces of blood ("occult blood") in the stool provide clues to colon cancer or precancerous lesions. For over 40 years, an enzymatic detection method has been used to detect the diseases. Now immunological ...

May 28, 2013
popularity not rated yet | comments 0

New method for predicting cancer virulence developed

A new way of tackling cancer and predicting tumor virulence are has been reported by a French team of scientists from the Institut Albert Bonniot de Grenoble including researchers from CNRS, Inserm and Université Joseph ...

May 26, 2013
popularity 5 / 5 (1) | comments 0